Mesoblast (MESO) Total Debt Growth (1y) (2019 - 2025)
Mesoblast (MESO) Total Debt Growth (1y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 103.99% |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 3.84% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.07% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Mesoblast | 2.08 Bn | 1.95 Bn | - | -116.89% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -116.89% |
| Jun 30, 2025 | 100.52% |
| Dec 31, 2024 | -141.53% |
| Jun 30, 2024 | 5.13% |
| Dec 31, 2023 | 15.85% |
| Jun 30, 2023 | 12.55% |
| Mar 31, 2023 | -111.29% |
| Dec 31, 2022 | -110.82% |
| Sep 30, 2022 | 341.66% |
| Jun 30, 2022 | 2.53% |
| Mar 31, 2022 | 91.63% |
| Dec 31, 2021 | 76.31% |
| Sep 30, 2021 | -61.99% |
| Jun 30, 2021 | -17.36% |
| Mar 31, 2021 | -22.84% |
| Dec 31, 2020 | -25.62% |
| Sep 30, 2020 | -13.54% |
| Jun 30, 2020 | 40.30% |
| Mar 31, 2020 | -14.62% |
| Dec 31, 2019 | 9.29% |